PharmaTech

MAY 4, 2023

In this episode of Drug Digest, Pharmaceutical Technology editors discuss the advantages and savings that continuous manufacturing may offer as well as the very real obstacles that might make a fully continuous process not feasible, especially in biologics manufacturing.

Manufacturing 52

Manufacturing Pharmaceutical 52

PharmaTech

MAY 24, 2023

In this episode of Drug Digest, Pharmaceutical Technology editors discuss what happens in early phase development, the role of CDMOs, and highlight the benefits and challenges of the outsourcing process.

Pharmaceutical 52

Pharmaceutical 52

PharmaTech

SEPTEMBER 27, 2023

In this episode of Drug Digest, Pharmaceutical Technology’s European/Senior Editor, Felicity Thomas, discusses small-molecule APIs, excipients, and formulation advances, including a discussion about novel approaches and solutions to pediatric formulations and taste-masking, a rundown of the fundamental stages of gaining a certificate of suitability (..)

Pharmaceutical 52

Pharmaceutical 52

PharmaTech

JULY 7, 2022

In this exclusive Drug Digest video, experts from Roche and MilliporeSigma divulge factors that could influence an organization to pursue specific biomolecules for development.

52

52

PharmaTech

JANUARY 31, 2024

Below is a list of IPEC Guides and Position Papers that are available as FREE downloads from the IPEC-Americas website.

52

52

PharmaTech

FEBRUARY 29, 2024

This discussion explores how the management and analysis of vast data generated by advanced analytical technologies are revolutionizing the drug discovery and development process within the biopharma industry.

Biopharma 52

Biopharma Management 52

Pharmaceutical Technology

SEPTEMBER 6, 2023

Mirum Therapeutics acquired Travere’s Cholbam and Chenodal drugs that are approved to treat rare disorders.

52

52

European Pharmaceutical Review

OCTOBER 13, 2022

The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide. Traditionally, delivering protein drugs orally has been challenging. The capsule is also coated with small studs that brush mucus away.

Transportation 137

Transportation Engineering Leads Medical 137

PharmaTech

DECEMBER 6, 2022

Pharmaceutical Technology editors interview an automation expert from Automata on the benefits of automating entire workflows in analytics versus automating only specific pieces of equipment or only certain processes.

Biopharma 52

Biopharma Pharmaceutical 52

PharmaTech

FEBRUARY 21, 2024

Lipid-based formulations (LBFs) are complex mixtures of lipid, surfactant and solvent excipient, where the composition determines the potential impact of dispersion and digestion on drug solubilization.

52

52

PharmaTech

OCTOBER 5, 2022

Pharmaceutical Technology editors interview oral solid dosage development experts from Syntegon and Colorcon, with discussions centered on continuous OSD production, containment safety, and authentication at the dose level.

Safety 52

Safety Pharmaceutical 52

Teachntest

MAY 8, 2023

5 Domperidone Combinations and Their Uses Digestive problems are some of the most common health issues faced by people worldwide. Medications are often prescribed to alleviate such symptoms, and two common types of drugs are proton […]

Medical 63

Medical Pharma 63

PharmaTech

JUNE 29, 2022

Thursday June 30, 2022 at 11am ET | 10am CT | 8am PT Cell and gene therapy (CGT) and antibody-drug conjugate (ADC) developers and manufacturers discuss factors that could influence organizations to pursue specific biomolecules for development.

Manufacturing 52

Manufacturing Pharmaceutical 52

PharmaTech

SEPTEMBER 29, 2022

Thursday, September 28, 2022 at 11am ET | 10am CT | 8am PT Learn the key benefits of continuous OSD production as well as the importance of authenticating OSD products at the dose-level with experts from Syntegon and Colorcon in this episode of the PharmTech Drug Digest Video Series.

52

52

Pharmaceutical Technology

APRIL 5, 2023

On the same day, the Cystic Fibrosis Foundation announced the funding for Anagram under its venture philanthropy model designed to provide financial support to “de-risk CF drug discovery and development”. If trials are successful, Anagram’s therapy will reduce the number of enzyme pills patients need to take with meals to help digest food.

Food 52

Food Patients Leads Pharmaceutical 52

European Pharmaceutical Review

OCTOBER 17, 2022

and Parkinson’s UK’s drug development and discovery division, Parkinson’s Virtual Biotech , will collaborate on a new Phase II trial to study the effects of the drug ENT-01 on Parkinson’s Disease (PD)-associated dementia. . The drug ENT-01 helps to inhibit ?S US biopharma company Enterin Inc. Given orally, ENT-01 targets

Biopharma 94

Biopharma Patients Pharmaceutical Marketing 94

Pharmaceutical Technology

JUNE 10, 2023

According to GlobalData, Phase II drugs for Chondrosarcoma does not have sufficient historical data to build an indication benchmark PTSR for Phase II. GlobalData uses proprietary data and analytics to create drugs-specific PTSR and LoA in the TAS-117 LoA Report. Buy the report here. It is a small molecule administered by orally.

Pharmaceutical 40

Pharmaceutical Pharmaceutical products Medicine Competition 40

Pharmaceutical Technology

JUNE 10, 2023

According to GlobalData, Phase II drugs for Chondrosarcoma does not have sufficient historical data to build an indication benchmark PTSR for Phase II. GlobalData uses proprietary data and analytics to create drugs-specific PTSR and LoA in the TAS-117 LoA Report. Buy the report here. It is a small molecule administered by orally.

Pharmaceutical 40

Pharmaceutical Pharmaceutical products Medicine Competition 40

Salesforce

FEBRUARY 20, 2024

Here are four steps life sciences organizations can take to improve patient experiences and develop more patient-centric approaches to drug and therapy discovery, development, and marketing. Simple, clear communications that avoid ‘medicalese’ can go a long way in doing so.

Patients 137

Patients Pharma Consulting Leads 137

European Pharmaceutical Review

SEPTEMBER 28, 2022

US participants took the medications in addition to metformin, a common type 2 diabetes drug, as type 2 diabetic patients often need to be prescribed more than one medicine to control their blood sugar levels. If approved as a treatment, the findings give the diabetic population a more positive future, regarding management of their condition.

Medicine 52

Medicine Medical Patients FDA 52

PM360

MAY 15, 2023

These are the critical moments when prescribers are speaking with their patients and in the mindset of connecting with and digesting the message. With a trigger-based messaging approach, marketers keep prescribers well informed about drugs and therapies allowing them to take decisive action.

Marketing 52

Marketing Prescription Patients Education 52

Contrarian Sales Techniques

JUNE 18, 2023

Highlighting Benefits "Given that Drug X excels in decreasing blood pressure, particularly in older patients, with an excellent side effect profile, low maintenance dosing, and high compliance." You should initiate patients with a dose of 5 mg once daily and allow some time for Drug X to take effect, considering its gradual onset of action.

Pharmaceutical Sales 52

Pharmaceutical Sales Sales Pharmaceutical Doctors 52

Pharma Marketing Network

DECEMBER 6, 2021

Digestive, gut health, Crohn’s Disease/Ulcerative Colitis. Alcohol/tobacco/drug use and cessation. Dietary supplements & vitamins. Cancer types, diagnosis & treatments. Alzheimer’s, dementia diagnosis & care. Respiratory illnesses, COPD, asthma, bronchitis. Relaxation techniques, meditation, yoga. Arthritis, carpal tunnel.

Healthcare 52

Healthcare Healthcare Engineering Leads 52

pharmaphorum

DECEMBER 14, 2022

Almost all patients treated with Novartis’ drug had no need for blood transfusions over the course of the study. Amgen’s drug plus chemo reduced the risk of death by 58% compared to chemo alone when given during the consolidation stage of treatment, with 83% and 65% of patients respectively still alive after 3.5

Side effects 52

Side effects Patients Sales Safety 52

PM360

NOVEMBER 27, 2023

Today, the timeline to bring drugs to market and educate customers is reduced. Building a solid content foundation is crucial, as we need to deliver more educational material to HCPs and patients that is simple and digestible, yet also compelling. Now, due to the highly competitive environment, the process is truncated to 12-18 months.

Marketing 105

Marketing Customer Relationship Management Relationship management Education 105

Pharmaceutical Technology

JUNE 29, 2022

The pharmaceutical industry often relies on enzymes to perform a process known as biocatalysis, which facilitates the cost-effective and sustainable production of small molecule drugs at scale. The post Enabling the next wave of innovative drug therapies with speciality enzymes appeared first on Pharmaceutical Technology.

Specialization 118

Specialization Biopharma B2B Sales Manufacturing 118

European Pharmaceutical Review

SEPTEMBER 25, 2023

Of particular interest is the potential of using NMR relaxometry as a point of receipt technique to satisfy regulatory identity testing requirements for active pharmaceutical ingredients (API) and drug product materials. Validation of capillary zone electrophoretic method for evaluating monoclonal antibodies and antibody-drug conjugates.

Pharmaceutical 98

Pharmaceutical Manufacturing Food Electronics 98

European Pharmaceutical Review

AUGUST 31, 2023

In addition, radionuclide therapy has the potential to achieve high efficacy rates since the administered drugs spare surrounding healthy tissue, thus, reducing the burden on the patient. 1-4 Besides these drug products, several companies worldwide are developing radiotheranostics in clinical trials built on various radionuclides.

Food and Drug Administration 85

Food and Drug Administration Manufacturing Safety Transportation 85

pharmaphorum

AUGUST 4, 2022

Mobile-friendly content is easily digestible and helps staff across all levels learn seamlessly throughout the day. Condensed, bite-sized modules and courses retain better attention from employees, especially when dispersing large amounts of crucial information across the business.

Recruitment 91

Recruitment Pharma Training Pharmaceutical manufacturing 91

Clarify Health

DECEMBER 21, 2021

It requires that health plans publicly disclose pricing for in-network rates, billed charges, prescription drugs, and the allowed amounts for out-of-network providers. The reality is that data published in 2022 will be difficult for providers, employers, and consumers to digest. The tool must be an internet-based cost estimator.

Healthcare 52

Healthcare Healthcare Networking Healthcare Provider 52

pharmaphorum

OCTOBER 11, 2022

So, historically – certainly pre-2000 – if you look at the way prescription drugs were communicated, it was very tightly controlled: it was pharma companies speaking to doctors and the doctor would speak to the patient and tell them what they thought the right solution was,” he said. Seedings of a digital therapeutic future.

Pharma 83

Pharma Medicine Doctors Patients 83

Impetus Digital

APRIL 24, 2023

However, MA must play a critical role in ensuring that digital information is factual, relevant, digestible, and tailored to the intended audience. MSLs will drive patient-centricity in drug development and transform patient engagement to a model in which patients are seen as essential industry partners throughout the brand life cycle.

Medical 52

Medical Education Physicians Healthcare 52

European Pharmaceutical Review

FEBRUARY 22, 2023

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. 3 Yet oral delivery of biologics remains a challenge: biotherapeutics are susceptible to rapid breakdown and digestion by gastrointestinal proteases/enzymes and suffer from poor intestinal absorption.

Food and Drug Administration 96

Food and Drug Administration Manufacturing Safety Pharmaceutical 96

European Pharmaceutical Review

OCTOBER 4, 2022

Researchers from the New Jersey Institute of Technology (NJIT), US, have developed a pioneering technique to test and produce new protein-based drugs, like therapeutic monoclonal antibodies (mAbs), which could help scientists develop better solutions to globally problematic diseases such as cancers and infectious illnesses. .

Safety 88

Safety Pharmaceutical Manufacturing Medicine 88

PharmaTech

SEPTEMBER 1, 2022

Pharmaceutical Technology editors interview aseptic and sterilization experts from Watson-Marlow Fluid Technology Solutions and Cherwell—diving into sterilization, aseptic processing, and the revised EU GMP Annex 1 guidance.

Pharmaceutical 98

Pharmaceutical 98

Legacy MEDSearch

FEBRUARY 21, 2023

Food and Drug Administration (FDA) 510(k) clearance for DiLumen EZ¹, a single-use, disposable endotherapy device for endoscopic mucosal resections (EMR) and difficult colonoscopies. Connecticut-based medical device innovator Lumendi, LLC announced that it has received U.S. Since 2017, clinicians in the U.S.,

Food and Drug Administration 98

Food and Drug Administration Recruitment Medical Distribution 98

PharmaTech

AUGUST 21, 2023

From stumbling over a journal article in a library to developing a new form of analytical technology, Sean Hart, PhD, covered an exciting journey with laser force technology.

Manufacturing 40

Manufacturing 40